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Background
The Dopamine Augmented Rehabilitation in Stroke
(DARS) trial is a double-blind placebo controlled trial
investigating impact of co-careldopa/placebo in combi-
nation with routine NHS occupational/physical therapy
on functional outcome in people with acute stroke. The
trial involves participants taking Investigational Medic-
inal Product (IMP)/placebo prior to therapy sessions
while in the acute stroke unit and following hospital
discharge
Stroke survivors may have significant residual impair-
ments such as weakness, aphasia, visual disturbance,
cognitive problems and mood disorders which may
affect their ability to comply with DARS medication/
therapy schedule.
Objectives
To identify issues in adherence and retention to medica-
tion/therapy schedule and implement processes to maxi-
mise compliance across hospital and community
settings.
Methods
Key aspects of compliance with the medication/therapy
schedule included (a) ensuring IMP packaging was clear
and useable by people with hemiparesis; (b) IMP was
taken at the correct time in relation to therapy
intervention.
Packaging & labelling
We involved 19 stroke survivors in small group discus-
sions about different aspects of IMP labelling and packa-
ging. Different examples of IMP packaging(developed
using NPSA guidance) were presented and preferences/
opinions were obtained through standardised
questionnaires.
Compliance with therapy / medication schedule
We developed a DVD for the participant/carers to view
in their home environment to provide an audio visual
aid to supplement the Patient Information Sheet. The
DVD included voice over explaining trial processes in
particular the therapy/IMP schedule, safety issues and
contact details. IMP/therapy schedule compliance was
also discussed with community therapists.
Results
The patient feedback was incorporated into IMP packa-
ging to allow one handed opening and prompts for
adherence to IMP schedule.
The DVD content is presented in a manner accessible
to patients with aphasia or hemisensory neglect and
uses graphics to illustrate abstract concepts such as ran-
domisation. The DVD will be given to trial participants
as part of the recruitment information pack.
A process has been implemented for the therapist (a)
to call the patient 45 minutes before the therapy session
to remind the patient to take their IMP and (b) to con-
duct a compliance check at each therapy session.
Conclusions
The trial opened to recruitment in May 2011. An eva-
luation of the above approaches has been build into the
trial follow up outcome visits. Recruitment, adherence
to trial protocol and patient satisfaction with informa-
tion provided will be used as outcomes to judge impact
of above strategies.
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